Open AccessEvaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson’s Disease
Author(s) -
Wolfgang H. Jost
Publication year - 2022
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s279362
Subject(s) - medicine , entacapone , dyskinesia , tolerability , levodopa , parkinson's disease , disease , catechol o methyl transferase , adverse effect , intensive care medicine , allele , biochemistry , chemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom